HeartFlow said today that it named former Beaver-Visitec prez & CEO Dana Mead, Jr., as its new president and CEO, replacing current prez & CEO Dr. John Stevens, who will continue to serve on the board as chair. Prior to joining Beaver-Visitec, Mead served as a strategic advisor and partner in Kleiner Perkins Caufield & […]
ClearFlow raised $7.2 million in a new round of equity financing, according to an SEC filing posted this week. Money in the offering came from five anonymous investors, with the first sale recorded on February 15. The Anaheim, Calif.-based company is looking for an additional $3 million before closing the offering, according to an SEC […]
ClearFlow said today it won FDA 510(k) clearance for its FlowGlide active clearance technology system designed to prevent or reduce clot occlusions during chest drains. The Anaheim, Calif.-based company said that the device is designed to prevent retained blood syndrome, which can be detrimental to outcomes after cardiothoracic surgery and may require late interventions. “ClearFlow is […]
From new and renewed partnerships to FDA approvals, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Life Spine receives FDA clearance for cervical spacer system Life Spine announced in an April 19 press release that it has received FDA 510(k) clearance for its Plateau-C Ti Cervical Spacer […]
ClearFlow said today it launched its PleuraFlow device designed for removing clots from chest tubes used to evacuate shed blood during pediatric cardiothoracic surgeries. The Anaheim, Calif.-based company said it won FDA 510(k) clearance earlier this year expanding the indications of use for a PleuraFlow system for pediatric patients. “We commonly hear from pediatric heart […]
Clear Catheter Systems Inc. said it raised $3.8 million in an equity round.
The Bend, Ore.-based company’s goal is to raise $4 million from the sale, according to a regulatory filing.
Three unnamed investors participated in the round, according to the filing.
Conceptus (NSDQ:CPTS) swapped out $50 million worth of 2.25% senior notes due 2027 from a select group of holders, exchanging them for 5% notes due 2031, regulatory filings show.
The principal amount on the new notes was an even swap for the originals, which was determined in individual negotiations between Conceptus and the holders.
Cleveland Clinic spinoff Clear Catheter Systems, which recently closed a $1.2 million angel investment round, received Food & Drug Administration 510(k) clearance to sell its PleuraFlow Active Tube-Clearance System in the United States.
PleuraFlow keeps catheters clear while draining blood and other fluids from the chest after heart or lung surgery. The device has the potential to improve patient outcomes, said Dr. Edward Boyle, Clear Catheter’s CEO.
Cleveland Clinic spinoff Clear Catheter Systems Inc. raised $1.2 million in equity to help support the launch of its lead product, PleuraFlow.
The Bend, Ore.-based company’s PleuraFlow active tube-clearance system uses magnets and a wire loop to keep catheters clear while draining blood and other fluids from the chest after heart or lung surgery. Passive tubes can clog, posing threats like infection and death.
By Mary Vanac
Clear Catheter Systems received regulatory clearance for its active catheter-clearance system PleuraFlow in Europe.
The spin-off from the Cleveland Clinic so far has the European Union’s CE Mark and approval from Health Canada, but the company is still awaiting a nod from the Food & Drug Administration to sell its self-clearing catheter system in the United States.